MMT International Trademark (WIPO) Information
Therapeutic pharmaceuticals for medical use for the
treatment of dysbiosis, infectious diseases, inflammatory
diseases, cancer, gastro-intestinal diseases, metabolic
diseases and disorders, cardiovascular diseases and
disorders, immune disorders, kidney diseases and disorders,
liver diseases and disorders, organ failure, autoimmune
diseases, brain conditions, genetic disorders, drug-induced
toxicities, allergies, depression, autism spectrum
disorders, obesity, and diabetes in humans; dietetic foods
adapted for medical use; dietary supplements; nutritional
supplements; nutraceuticals for the treatment of dysbiosis,
infectious diseases, inflammatory diseases, cancer,
gastro-intestinal diseases, metabolic diseases and
disorders, cardiovascular diseases and disorders, immune
disorders, kidney diseases and disorders, liver diseases and
disorders, organ failure, autoimmune diseases, brain
conditions, genetic disorders, drug-induced toxicities,
allergies, depression, autism spectrum disorders, obesity,
and diabetes in humans; medical diagnostic reagents and
assays for testing body fluids for microorganisms for
modifying the microbial composition or metabolic output...
Perfect for these industries
Words that describe this mark
therapeutic pharmaceuticals medical use treatment dysbiosis infectious diseases inflammatory diseases cancer gastrointestinal diseases metabolic diseases disorders cardiovascular diseases disorders immune disorders kidney diseases disorders liver diseases disorders
Abandonment Notice!
On Monday, November 28, 2022,
status on the MMT
trademark changed to be EXPIRED.
On Wednesday, June 19, 2019, an International Trademark registration was filed for
MMT by Kaleido Biosciences, Inc. *********, **********, ***** ****.
The World Intellectual Property Organization (WIPO) has given the trademark application number of
1482563.
The expiration date for this trademark is 11/28/2022.
The MMT
trademark is filed in the description of
Therapeutic pharmaceuticals for medical use for the
treatment of dysbiosis, infectious diseases, inflammatory
diseases, cancer, gastro-intestinal diseases, metabolic
diseases and disorders, cardiovascular diseases and
disorders, immune disorders, kidney diseases and disorders,
liver diseases and disorders, organ failure, autoimmune
diseases, brain conditions, genetic disorders, drug-induced
toxicities, allergies, depression, autism spectrum
disorders, obesity, and diabetes in humans; dietetic foods
adapted for medical use; dietary supplements; nutritional
supplements; nutraceuticals for the treatment of dysbiosis,
infectious diseases, inflammatory diseases, cancer,
gastro-intestinal diseases, metabolic diseases and
disorders, cardiovascular diseases and disorders, immune
disorders, kidney diseases and disorders, liver diseases and
disorders, organ failure, autoimmune diseases, brain
conditions, genetic disorders, drug-induced toxicities,
allergies, depression, autism spectrum disorders, obesity,
and diabetes in humans; medical diagnostic reagents and
assays for testing body fluids for microorganisms for
modifying the microbial composition or metabolic output of
the human microbiome.
.
100% Satisfaction Guarantee
protect your valuable brand now.
Classification Information
| Class Code: |
005 - Pharmaceutical Products
|
| Class Description: |
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
|
| Goods & Services: |
Therapeutic pharmaceuticals for medical use for the
treatment of dysbiosis, infectious diseases, inflammatory
diseases, cancer, gastro-intestinal diseases, metabolic
diseases and disorders, cardiovascular diseases and
disorders, immune disorders, kidney diseases and disorders,
liver diseases and disorders, organ failure, autoimmune
diseases, brain conditions, genetic disorders, drug-induced
toxicities, allergies, depression, autism spectrum
disorders, obesity, and diabetes in humans; dietetic foods
adapted for medical use; dietary supplements; nutritional
supplements; nutraceuticals for the treatment of dysbiosis,
infectious diseases, inflammatory diseases, cancer,
gastro-intestinal diseases, metabolic diseases and
disorders, cardiovascular diseases and disorders, immune
disorders, kidney diseases and disorders, liver diseases and
disorders, organ failure, autoimmune diseases, brain
conditions, genetic disorders, drug-induced toxicities,
allergies, depression, autism spectrum disorders, obesity,
and diabetes in humans; medical diagnostic reagents and
assays for testing body fluids for microorganisms for
modifying the microbial composition or metabolic output of
the human microbiome. |